Search

Filters
Clear All
  • 2
  • 14
  • 43

Phase

  • 3
  • 1
  • 16
  • 3
  • 14
  • 1
  • 21
  • 58
  • 4

Found 59 site-public-contact trials

A listing of site-public-contact medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A
Anita Turk, MD
18 years - 100 years
All genders
This study investigates the safety and effects of an investigational medication in combination with other agents for patients with pancreatic or non-small cell lung cancer. These cancers are being studied because they have specific genetic changes called MTAP loss and RAS mutation. The purpose is to see how the investigational …
S
Sharon E. Robertson
18 years - 100 years
Female
Phase 3
This study investigates treatment options for high risk locally advanced cervical cancer, where the cancer has spread to nearby tissues or lymph nodes. The study compares two approaches: one with induction chemotherapy using an investigational medication and chemotherapy, followed by chemoradiation and maintenance therapy, and the other with just chemoradiation …
G
Greg Durm, MD
18 years - 100 years
All genders
Phase 1
This study investigates the safety and effects of an investigational antibody-drug conjugate in patients with advanced or metastatic solid tumors. The purpose is to understand how the investigational medication works in the body and its impact on tumors. Advanced or metastatic solid tumors are cancers that have spread beyond their …
N
Nabil Adra, MD
18 years - 100 years
Male
Phase 2/3
This study investigates the treatment of PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) using an investigational medication called AAA817. The purpose of this study is to compare the effects of AAA817 with the standard of care treatment in adults who have already been treated with certain cancer therapies but have not …
A
Amanda J. Saraf, DO
1 year or below
All genders
Phase 2
This study investigates the addition of investigational medication and investigational immunotherapy to the usual chemotherapy for infants with newly diagnosed acute lymphoblastic leukemia (ALL). ALL is a type of cancer where the bone marrow makes too many immature lymphocytes (a type of white blood cell). In this study, the researchers …
T
Tareq Salous
18 years - 100 years
All genders
Phase 3
This study investigates how well an investigational medication combination works in treating adults with untreated locally advanced or metastatic urothelial carcinoma with an FGFR3 genetic alteration. Urothelial carcinoma is a type of cancer that occurs in the urinary system. This study uses a combination of medications, including monoclonal antibodies, which …
H
Hristos Kaimakliotis, MD
18 years - 100 years
All genders
Phase 2
This study investigates the safety and efficacy of intravesical nadofaragene firadenovec, either alone or in combination with chemotherapy or immunotherapy, in patients with high-grade Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer (NMIBC). NMIBC is a type of bladder cancer that has not spread into the muscle layer of the …
N
Namita Agrawal
18 years or above
Female
Interventional
This study investigates the feasibility of adding pre-rehabilitation pelvic health physical therapy to the standard radiation treatment plan for women with certain types of cancer. These include cervical, vaginal, vulvar, uterine, or anal cancer. Participants will receive education on using a vaginal dilator during their treatment. The study will also …
U
Utpal Dave, MD
18 years - 75 years
All genders
Phase 3
This study investigates the potential benefits of using high dose chemotherapy followed by a patient's own stem cells, known as an autologous stem cell transplant, in treating peripheral T-cell lymphoma. Peripheral T-cell lymphoma is a type of cancer that affects T-cells, which are part of the body's immune system. The …
51 - 59 of 59